Placenta immune infiltrates and perinatal outcomes

Area of Science:

• Reproductive immunology
• Cancer immunology
• Maternal-fetal medicine

Background:

• Pregnancy requires a delicate balance of maternal immune tolerance to prevent fetal rejection.
• Dysregulation of this immune tolerance is linked to adverse pregnancy outcomes and complications.
• The maternal immune system undergoes significant adaptations to accommodate the semi-allogeneic fetus.

Purpose of the Study:

• To compare and contrast the immunobiology of healthy versus pathological pregnancies.
• To draw parallels between pregnancy immune adaptations and cancer immune evasion mechanisms.
• To focus on the role of immune checkpoint receptors in both contexts.

Main Methods:

• Comparative analysis of immune responses in healthy and complicated pregnancies.
• Review of existing literature on pregnancy immunobiology and cancer immunology.
• Examination of immune checkpoint receptor expression and function in feto-maternal tolerance and cancer.

Main Results:

• Mechanisms sustaining healthy pregnancy, like regulatory T cell predominance, can paradoxically facilitate immune evasion seen in cancer.
• Immune pathways crucial for cancer elimination are fundamentally involved in the breakdown of feto-maternal tolerance.
• Immune checkpoint receptors play a critical role in modulating the maternal immune response during pregnancy and in cancer.

Conclusions:

• Understanding the shared immunobiology between pregnancy and cancer offers insights into novel therapeutic targets.
• Dysregulation of immune checkpoints is implicated in both pregnancy complications and cancer progression.
• Further research into these shared pathways could improve management of pregnancy disorders and cancer immunotherapy.